Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: KFF; Chart: Will Chase/Axios

Americans are more convinced by the arguments made in favor of allowing the government to negotiate prescription drug prices than they are by those made against the policy, which the drug industry argues would lead to fewer new drugs, according to new KFF polling.

Between the lines: Just because the measure is popular with the public doesn't mean it'll pass, and it's currently in serious hot water with moderate Democrats.

What they found: The poll asked respondents whether they found two different arguments convincing.

  • The first argument was that allowing Medicare to negotiate drug prices "would have the government too involved and will lead to fewer new drugs being available in the future," which is the argument being made by pharma and its allies.
  • A third of respondents said they found this argument very or somewhat convincing.
  • The second argument, which is made by advocates of the measure, was that "this is needed because Americans pay higher prices than people in other countries, many can’t afford their prescriptions, and drug company profits are too high."
  • 84% of respondents said they found the argument very or somewhat convincing.

By the numbers: More than half of respondents — including 44% of Republicans — said they strongly favored the measure before hearing the arguments for and against it, and another 31% somewhat favored it.

  • Strong support slid a few percentage points to 45% after hearing the arguments, but the portion of respondents who said they somewhat favor the measure rose to 37%, leaving overall favorability unchanged.
  • One in five seniors said they struggle to afford their prescription drugs.

What we're watching: Democrats are currently seeking a version of Medicare negotiations that can pass the House and Senate.

  • Of course, if they're successful, public opinion today isn't an indicator of public opinion in the future, nor is it indicative of how the policy would play out in real life.

Go deeper

Oct 19, 2021 - Health

FDA moves to allow sale of over-the-counter hearing aids

Photo: Sarah Silbiger/Getty Images

A new proposal from the Food and Drug Administration on Tuesday marked the first step in allowing a new category of hearing aids to be sold over the counter without a medical exam or audiologist fitting.

Why it matters: Advocates and lawmakers who have long pushed for over-the-counter hearing aids say the market for the products, if the proposal is approved, would look like the eye care industry, in which consumers have choices to purchase reading glasses and bifocals through their doctor's office or elsewhere.

Bryan Walsh, author of Future
2 hours ago - Politics & Policy

Axios AM Deep Dive: America’s murder surge

Photo illustration: Sarah Grillo/Axios. Photo: Erik McGregor/LightRocket via Getty Images

Homicides rose at the fastest rate in at least six decades last year. This Axios AM Deep Dive, led by Future correspondent Bryan Walsh, looks at the state of gun crime.

6 hours ago - Politics & Policy

Senate Democrats target billionaires

Illustration: Annelise Capossela/Axios

After failing to get a deal on other planned tax increases, key Senate Democrats are pivoting to a billionaires' income tax to pay for President Biden's social spending.

The big picture: No advanced economy has attempted anything similar on such a scale.